Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

2017 Agenda

Opening Keynote Morning
08:30 - 09:00
The journey to the beginning: How AstraZeneca defined patient centricity and the impact on the organisation
  • Learn how AZ has established some basic principles for a patient centric transformation program as it begins to refocus on how to engage patients.
  • Listen to how is AZ creating that momentum for change to build sustainable practices for the future
  • How is AZ demonstrating impact for patients?

AstraZeneca Guy Yeoman Vice President, Patient Centricity AstraZeneca

09:30 - 10:00
Culture eats strategy: how Ipsen change company mindset?
  • Determine whether culture change should be top-down or bottom-up
  • Engage employees to work and involve patients at every stage of the value chain
  • Avoid mandatory training by supporting your colleagues to take pro-active steps to engage with patients in all cross-functional areas

Ipsen Isabelle Bocher Pianka Chief Patient Officer Ipsen

09:30 - 10:00
“Our customer is the patient:” Is UCB’s patient-focussed model delivering performance?
  • A close examination of whether UCB’s efforts to transform its DNA is creating commercial, cultural and collaborative capital
  • Appreciate the impact patient engagement is having on the company’s commercial goals

UCB Analia de la Fuente Vice President & Global Head of Patient Ecosystem Insights Practice UCB

09:00 - 09:30
Explore Empathy: How Takeda’s #FlywithIBD and #InTheirShoes programmes deepened patient understanding and inspired collaboration with staff and HCPs
  • Understand the oft-overlooked role of your internal communications team in supporting patient outcomes
  • Do experiential programmes always work? An examination of results to date, lessons learned and future directions

Takeda Robert Gallo Head of Corporate Communications Europe/Canada Takeda

Real insights for real impact
08:30 - 09:00
Patient Panel - We believe, but do patients see us as their partner of choice? The roadmap to gaining trust and rebuilding pharma’s reputation
  • Assess the most recent results of the PatientView Global Corporate Reputation Report – why is pharma not meeting society’s expectations?
  • Why the partnership, support and even creation of long-term associations makes sense within your business model
  • How patient associations can trigger the fundamental reorientation of employee attitudes towards your company’s success

Moderator: Teva Ruth Wilson Global Head of Patient Advocacy Teva

Panelists: Patient View Alexandra Wyke CEO Patient View

WAPO - World Alliance of Pituitary Organizations Sheila Khawaja Vice-Chair WAPO - World Alliance of Pituitary Organizations

Epilepsy Society UK Jasmine Smith Member of Trustee Board Epilepsy Society UK

08:30 - 09:00
Effective ways to educate external partners and patients about the benefits and process regarding co-creation or consultation

European Society for Person Centered Healthcare Andrew Miles Senior Vice President & Secretary General European Society for Person Centered Healthcare

08:30 - 09:00
Defining the best profile of a therapy - Focus on the pathway, not the drug. Establish partnerships with patients which add value to the drug development based on unmet medical needs.
  • How to “translate” patient expectations and unmet needs to pathways and targets
  • How to define profile of an “ideal” therapy together with patients
  • Determine when and where patient-industry collaborations make sense.

ViiV Healthcare Dr Oleksandr Gorbenko, MD, PhD Global Patient Affairs Medical Lead ViiV Healthcare

08:30 - 09:00
One size does NOT fit all: how to create personalised and engaging patient support programs
  • With the use of a combined behavioural psychology and a storytelling approach, examine why beliefs and motivations matter
  • Understand the role that pharma can play in helping patients to develop new skills and change behaviour
  • Learn how behavioural change can increase patient adherence and self-management

Teva Carla Van De Guchte Director of European Operations, Patient Solutions Teva

08:30 - 09:00
Never give up! Learn how Shire overcame challenges on the implementation of a Patient Support Programme by using patient data
  • Create defined objectives, co-ordinate organised exit strategies, centralise patient relationships
  • How to select and work with fewer, quality partners who generate real value – and even overcome compliance issues
  • How to use data to support decision making, clear obstacles and make your patient-focussed decisions more reliable

Shire Thomas Kerscher Global Head Patient & Customer Excellence Shire

Use digital technology to put the solution in your patient’s hands
08:30 - 09:00
Use digital technology to put the solution in your patient’s hands: how pharma can be disruptive and provide innovation around experiences
  • Embrace a different mindset to transform patient self-care empowerment into a holistic experience
  • Explore how digital solutions can fit into the changing landscape
  • Learn from pilots how value-adding digital services can optimise chronic patient care interventions

Sanofi Jan Liska Global Head of Patient Business Strategy Sanofi

08:30 - 09:00
Hear the patient’s voice - how patient centricity at AstraZeneca has accelerated through the use of personalised health networks
  • Listen to how the collaboration between AstraZeneca and PatientsLikeMe has helped teams rapidly identify outcomes that matter to patients
  • Understand what impacts patient experience of research and how to make it easier for patients to join and stay in clinical studies

Cathy Emmas Cathy Emmas Patient Centricity Partnership Director AstraZeneca

PatientsLikeMe Dr. Paul Wicks Vice President of Innovation PatientsLikeMe

08:30 - 09:00
AbbVie’s YouTube Doctor’s Channel – giving physicians a voice
  • See how AbbVie became the trusted partner by simplifying complex medical information and making it accessible to patients by using physicians as online coaches.
  • Where quality shines through: how and why the channel quickly became popular and respected, and the measured impact on patients
  • Understand what internal and external support was required to make the product work,

AbbVie Fiona Olivier Director of Public Affairs, Western Europe & Canada AbbVie

08:30 - 09:00
How LEO Innovation Lab used lessons from successful viral companies to create a new type of patient solution
  • Learn how ‘TREAT’ was incubated by LEO Innovation Lab (an independent unit of LEO Pharma dedicated to building new solutions).
  • A look at the scientific framework and behaviour change theory used to guide people through an individualised programme to help them understand, try and adopt anti-inflammatory principles into their diet.
  • A look at the performance of the coaching app and how lessons from Clash of Clans, ASOS & LinkedIn were adopted to encourage adherence.

LEO Innovation Lab Tom Traberg Stenson Product Owner TREAT LEO Innovation Lab

LEO Innovation Lab Kyla Newcombe DipION, BSc, MSc Lead Nutrition Coach TREAT LEO Innovation Lab

08:30 - 09:00
Fight Idiopathic pulmonary fibrosis (IPF) with Roche!
  • From idea to implementation: how Roche built the innovative FightIPF campaign across Europe and Canada to raise awareness of an aggressive, unpredicatable disease.
  • A look at how Roche was inspired by the Philips Breathless Choir ro develop an integrated campaign, with a hero video sitting at the very core.
  • How compliance and internal support issues were fought for the good of the patient.

Roche Peter Verwaijen International Product Manager  Roche

The virtuous circle – Move beyond collaboration and drive behaviour internally and externally to improve outcomes
08:30 - 09:00
A systematic approach to building patient engagement
  • Understand the patient engagement landscape, open collaboration and actionable tools
  • Learn how to create a movement to drive culture change and scale it
  • Lesson learned to deliver better patient outcomes

PFMD Nicholas Brooke Chief Executive PFMD

Three more PFMD executive members to be revealed

08:30 - 09:00
Risk-share with a patient support programme – how UCB changed the rules with its Health Ecosystem Solution Project
  • Understand the essential foundations of a focus on solutions beyond the pill which impact patient lives and create extensive stakeholder value.
  • Learn how the project moved the narrative within UCB from merely treating patients to taking care of people, designing and implementing patient solutions that truly impact lives.
  • The requirements for a risk-sharing agreement with a patient support programme

UCB Cristina Ferragut Project Leader of Health Ecosystem Solution UCB

Spanish Pharmacy National Society Jose Manuel Sesmero Innovation Manager Spanish Pharmacy National Society

08:30 - 09:00
Make engagement happen: overcome the barriers to patient involvement
  • A guide to the BREATHE principles and the essentials of all patient outreach
  • Smart ways to measure engagement and communicate progress internally
  • Truth in technology: move beyond buzzwords and see what really works
  • Stay compliant by involving your legal team in developing frameworks and guidelines

Grünenthal Emma Sutcliffe Consultant, Patient Engagement Grünenthal

Download your event brochure today

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown